<p>There was significant heterogeneity between AD and healthy controls. Abbreviations: a-MCI, amnestic mild cognitive impairment; na-MCI, non-amnestic mild cognitive impairment; AD, Alzheimer’s disease; non-AD, non-AD dementia.</p
dementia worldwide. It is characterized by two micro-scopic neuropathologic hallmarks- senile plaque...
Objective: We investigated differences in regional cortical thickness between previously identified ...
Objectives: The criteria for objective memory impairment in mild cognitive impairment (MCI) are v...
BackgroundPrevious work examining normal controls from the Alzheimer's Disease Neuroimaging Initiati...
<p>Abbreviation: n is number of subjects we tested; n filt is number of subjects after filtering out...
<p>The clustering coefficients (<i>C<sub>p</sub></i>) from cognitively normal (CN, black dotted line...
<p>Abbreviations: AD, Alzheimer’s disease; aDMN, anterior default-mode network; aMCI, amnestic mild ...
Item does not contain fulltextBackground/Aims: To identify prodromal Alzheimer's disease (AD) subjec...
<p>Abbreviations; N, number of participants; M, Mean; SD, Standard deviation; NC, Normal Controls; M...
Objective: To investigate the effect of enriching mild cognitive impairment (MCI) clinical trials us...
<p>Abbreviations; NC, Normal Controls; MCI, Mild Cognitive Impairment; AD, Alzheimer’s disease; TMT-...
Mild Cognitive Impairment (MCI) is a heterogeneous condition between normal aging and dementia. Upon...
Heterogeneity of outcomes in Alzheimer's disease (AD) clinical trials necessitates large sample size...
OBJECTIVES: To investigate the implications of obtaining one or more low scores on a battery of cogn...
<p>The solid line shows the proportion of subjects predicted to progress from amnestic mild cognitiv...
dementia worldwide. It is characterized by two micro-scopic neuropathologic hallmarks- senile plaque...
Objective: We investigated differences in regional cortical thickness between previously identified ...
Objectives: The criteria for objective memory impairment in mild cognitive impairment (MCI) are v...
BackgroundPrevious work examining normal controls from the Alzheimer's Disease Neuroimaging Initiati...
<p>Abbreviation: n is number of subjects we tested; n filt is number of subjects after filtering out...
<p>The clustering coefficients (<i>C<sub>p</sub></i>) from cognitively normal (CN, black dotted line...
<p>Abbreviations: AD, Alzheimer’s disease; aDMN, anterior default-mode network; aMCI, amnestic mild ...
Item does not contain fulltextBackground/Aims: To identify prodromal Alzheimer's disease (AD) subjec...
<p>Abbreviations; N, number of participants; M, Mean; SD, Standard deviation; NC, Normal Controls; M...
Objective: To investigate the effect of enriching mild cognitive impairment (MCI) clinical trials us...
<p>Abbreviations; NC, Normal Controls; MCI, Mild Cognitive Impairment; AD, Alzheimer’s disease; TMT-...
Mild Cognitive Impairment (MCI) is a heterogeneous condition between normal aging and dementia. Upon...
Heterogeneity of outcomes in Alzheimer's disease (AD) clinical trials necessitates large sample size...
OBJECTIVES: To investigate the implications of obtaining one or more low scores on a battery of cogn...
<p>The solid line shows the proportion of subjects predicted to progress from amnestic mild cognitiv...
dementia worldwide. It is characterized by two micro-scopic neuropathologic hallmarks- senile plaque...
Objective: We investigated differences in regional cortical thickness between previously identified ...
Objectives: The criteria for objective memory impairment in mild cognitive impairment (MCI) are v...
DOI
Add to ORKG